期刊文献+

系统性疾病治疗与口腔病灶感染 被引量:2

The treatment of systemic diseases and oral focal infection
原文传递
导出
摘要 口腔病灶被证实与许多系统性疾病的发生及发展有很大的相关关系,全身系统性疾病的治疗又会加重口腔病灶的感染,影响患者的生存质量,干扰系统性疾病的治疗,严重则造成全身感染。可能诱发或加重口腔病灶感染的系统性疾病治疗有:口服抗癫痫药物、免疫抑制剂等药物导致的药物性牙龈炎;恶性肿瘤放化疗并发的口腔黏膜炎;长期应用抑制肿瘤骨转移或预防骨质疏松的双磷酸盐造成的颌骨坏死;异基因造血干细胞移植后的口腔排异反应等。 Oral lesions were proved to have high correlation with the occurrence and development of many diseases. On the other hand,treatment of systemic diseases may aggravate oral focal infections,affect life quality of patients,interfere the treatment of systemic diseases and cause severe systemic infection. These treatments of systemic diseases which may induce or aggravate oral local lesion infections include: some oral anti-epileptic drugs and immunosuppressive drugs that may induce gingivitis,radiotherapy or chemotherapy that can intrigue oral mucositis due to immune function damage,long-term use of bisphosphonates for inhibition of malignant tumor bone metastasis or prevention of osteoporosis that will cause osteonecrosis of the jaw,as well as allogeneic hematopoietic stem cell transplantation that may cause oral rejection reactions,etc.
出处 《中国微生态学杂志》 CAS CSCD 2015年第2期240-243,共4页 Chinese Journal of Microecology
基金 北京自然科学基金资助项目(7152110)
关键词 口腔病灶感染 系统性疾病 药物性牙龈炎 恶性肿瘤 双磷酸盐相关颌骨坏死 排异反应 Oral focal infection Systemic diseases Drug gingivitis Malignant tumor Bisphosphonate-related osteonecrosis of the jaw Rejection reactions
  • 相关文献

参考文献30

  • 1Destefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality [ J]. Clin Res, 1993, 306 (6879) : 688-691.
  • 2Kiran M, Arpak N, Unsal E, et al. The effect of improved perio- dontal health on metabolic control in type 2 diabetes mellitus[ J]. J Clin Periodontol, 2005, 32(3) : 266-272.
  • 3Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk fac tot for preterm low birth weight[ J]. J Periodontol, 1996, 67(10 Suppl): 1103-1113.
  • 4Cawley MM, Benson LM. Current trend in managing oral mucositis clinical[J]. Clin J Oncol Nurs, 2005, 9(5) : 584-592.
  • 5Epstein JB, Tsang AH, Warkentin D, et al. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucosi- tis : a review of the literature [ J ]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2002, 94(1): 39-44.
  • 6Pico JL, Avila-Garavito A, Naccache P. Mucositis: Its occurrence, consequences, and treatment in the oncology setting [ J]. Oncolo- gist, 1998, 3(6): 446-451.
  • 7Peterson DE. Oral toxicity of chemotherapeutic agents [ J ], Semin in Oncol, 1992, 19(5): 478-491.
  • 8Puyal-Casado M, Jim6nez-Martinez C, Chimenos-K6stner E, et al. A protocol for the evaluation and treatment of oral mucositis in patients with hematological malignancies [ J]. Med Oral, 2003, 8 (1): 10-18.
  • 9L6pez J, Sabater MM, Muoz J, et al. Evaluation and prevention of oral complications in patients subjeted to bone marrow transplanta- tion: A clinical study[J]. Med Oral, 2000, 5(5) : 345-354.
  • 10Woo S-B, Sonis ST, Monopoli MM, et al. A longitudinal study of 3ral ulcerative mucosistis in bone marrow transplant recipients[ J]. 2ancer, 1993, 72(5): 1612-1617.

同被引文献23

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部